SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer

SCYNEXIS, Inc. (NASDAQ: SCYX), a clinical-stage biotechnology company, has appointed Sanjay Subramanian as its new Chief Financial Officer, effective September 9, 2026. He succeeds Ivor Macleod, who retired from the role on the same date.